Global Idiopathic Pulmonary Fibrosis (IPF) Industry Forecast, 2030 - Competitive Landscape Assessment, Product Development & Innovation, Case Reports, Marketed Products & Emerging Therapies
February 28, 2022 06:23 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to ResearchAndMarkets.com's...
The Worldwide Pulmonary Drugs Industry is Expected to Reach $69+ Billion by 2027
February 02, 2022 05:18 ET
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Pulmonary Drugs Market (2021-2027) by Drug Class, Indication, Distribution Channel, and Geography, IGR Competitive Analysis, Impact of Covid-19,...
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2021: Market was Valued at $3271.3 Million in 2020 - Forecast to 2026
January 20, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market - Analysis By Drug Type, End User, By Region, By Country (2021 Edition): Market Insights, Pipeline...
Global Nasal Polyps Treatment Market Report 2021: A $4,243.9 Million Market by 2030
December 10, 2021 04:48 ET
|
Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Nasal Polyps Treatment Market Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering....
Global Anti-Asthmatics and COPD Drugs Markets Report 2021: Top 10 in Sales are Ellipta, Symbicort, Spiriva, Advair, Nucala, Xolair, Ventolin, Pulmicort, Fasenra, Flovent
December 09, 2021 03:33 ET
|
Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...
Global Trikafta Market Research Report 2021: Patents, Dosage & Prices, Sales, Clinical Trials, Chemistry & Pharmacokinetic Properties, Reimbursement Scenario - Outlook to 2028
December 08, 2021 07:28 ET
|
Research and Markets
Dublin, Dec. 08, 2021 (GLOBE NEWSWIRE) -- The "Trikafta Patent, Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. Global Trikafta market is...
COPD Epidemiology Analysis 2018-2020 and Forecasts 2021-2030 for the US, Germany, France, Italy, Spain, UK and Japan
December 02, 2021 05:03 ET
|
Research and Markets
Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report...
The Worldwide Lung Injury Industry is Expected to Reach $2+ Billion by 2030
November 05, 2021 08:23 ET
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Lung injury Market by Therapy, Injury Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Global Pneumonia Therapeutics Market (2021 to 2030) - by Therapeutics, Distribution Channel, Age Group and Region
November 05, 2021 08:08 ET
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Pneumonia Therapeutics Market by Therapeutics, Distribution Channel, and Age Group: Global Opportunity Analysis and Industry Forecast, 2021-2030"...
Insights on the Budesonide Inhaler Global Market to 2026 - Featuring Abbott Laboratories, AstraZeneca and Chiesi Farmaceutici Among Others
September 30, 2021 05:53 ET
|
Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Budesonide Inhaler Market Research Report by Dosage, by Products Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has...